MiMedx Group (MDXG) vs Shoulder Innovations (SI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Shoulder Innovations (SI) has outperformed MiMedx Group (MDXG) over the past year, gaining 37.2% versus a loss of 54.9%. MiMedx Group is the larger company by market cap ($445.1 million vs $421.6 million), about 1.1 times the size, while Shoulder Innovations is growing revenue faster (+49.6% vs +20.0%). MiMedx Group converts more of its revenue into profit, with a net margin of 11.6% versus -85.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDXG | SI |
|---|---|---|
| Share price | $3.05 | $20.15 |
| Market cap | $445.07M | $421.58M |
| 1-day change | -1.93% | -0.79% |
| YTD return | -54.95% | +40.91% |
| 1-year return | -54.88% | +37.17% |
| 5-year return | -58.62% | — |
| P/E ratio (TTM) | — | 17.99 |
| Forward P/E | 122.00 | — |
| EPS (TTM) | $-0.13 | $1.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $418.63M | $47.32M |
| Revenue growth (YoY) | +19.99% | +49.63% |
| Net income (latest FY) | $48.58M | $-40.36M |
| Gross margin | 82.56% | 76.51% |
| Operating margin | 15.26% | -55.58% |
| Net margin | 11.60% | -85.29% |
| 52-week high | $7.45 | $24.60 |
| 52-week low | $3.03 | $12.00 |
| Distance from 52-week high | -59.06% | -18.07% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +129.51% | +34.00% |
| Average volume | 1.39M | 120.15K |
| Shares outstanding | 145.93M | 20.92M |
| Employees | 808 | — |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SI has outperformed MDXG by 92.0 percentage points over the past year.
- MiMedx Group is more profitable, keeping 11.6 cents of every revenue dollar as net income versus -85.3 cents for Shoulder Innovations.
- Shoulder Innovations grew revenue faster in its latest fiscal year (+49.63% vs +19.99%).
About MiMedx Group
MDXG stock →MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.
Health Care · Medical/Dental Instruments · 808 employees
MDXG vs SI FAQ
Which is bigger, MiMedx Group or Shoulder Innovations?
MiMedx Group (MDXG) is larger, with a market capitalization of $445.07M compared with $421.58M for Shoulder Innovations (SI).
Which stock has performed better over the past year, MDXG or SI?
SI returned +37.17% over the past 12 months, compared with -54.88% for MDXG (price return, excluding dividends). Past performance does not predict future results.
Are MiMedx Group and Shoulder Innovations in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.